MD · MBA
Physician specializing in genetic analysis and personalized preventive medicine, and author of Outsmart Your Genes.
Brandon Colby is a physician-expert in the fields of genetic analysis and Personalized Preventive Medicine. He holds an MD from the Mount Sinai School of Medicine, an MBA from Stanford University's Graduate School of Business, and a degree in Genetics from the University of Michigan.
Dr. Colby is the author of the book Outsmart Your Genes and has developed numerous technologies that improve the analysis, interpretation, and actionability of genome sequencing data. He is an Affiliate Specialist of the American College of Medical Genetics and Genomics (ACMG), an Associate of the American College of Preventive Medicine (ACPM), and a member of the National Society of Genetic Counselors (NSGC).
Articles by Brandon Colby, MD are reviewed for accuracy by Sequencing's medical and scientific team. This page is for informational purposes and does not constitute medical advice.
Genetic testing unlocks diagnosis and treatment for Mitochondrial DNA Depletion Syndrome (MDDS), aiding early intervention and personalized management strategies.
Explore the role of genetic testing in managing MSH3-related AFAP, a hereditary condition leading to colorectal cancer. Enhance early detection and personalized care.
Explore the impact of genetic testing in diagnosing and managing MONA, a rare genetic disorder affecting bones, joints, and skin, offering new hope for patients.
Explore severe neonatal Multiple Acyl-CoA Dehydrogenase Deficiency (MADD): genetic testing benefits, early diagnosis, tailored treatment, and family planning insights.
Explore genetic testing for Muscular Dystrophy-Dystroglycanopathy, offering insights into diagnosis, treatment options, and family planning in this genetic disorder.
Explore the significance of genetic testing in diagnosing nebulin-related early-onset distal myopathy, aiding in early diagnosis, management, and research advancements.
Explore how genetic testing helps detect neural tube defects early. Understand ARMC5 mutations' role in NTDs and personalized prevention strategies.
Navigate NBIA with genetic testing for precise diagnosis, treatment guidance, and family planning. Enhance research and therapy development.